Insider Buying: Neonc Technologies Holdings, Inc. (NASDAQ:NTHI) President Buys $12,016.00 in Stock

Neonc Technologies Holdings, Inc. (NASDAQ:NTHIGet Free Report) President Amir F. Heshmatpour bought 1,600 shares of Neonc Technologies stock in a transaction dated Sunday, May 11th. The shares were acquired at an average cost of $7.51 per share, for a total transaction of $12,016.00. Following the completion of the purchase, the president now directly owns 1,751,600 shares of the company’s stock, valued at approximately $13,154,516. This trade represents a 0.09% increase in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.

Neonc Technologies Stock Performance

NTHI opened at $7.18 on Thursday. Neonc Technologies Holdings, Inc. has a 52-week low of $4.11 and a 52-week high of $25.00. The company’s 50 day simple moving average is $7.78.

Neonc Technologies (NASDAQ:NTHIGet Free Report) last posted its earnings results on Friday, May 9th. The company reported ($2.10) earnings per share (EPS) for the quarter. The firm had revenue of $0.04 million during the quarter.

Hedge Funds Weigh In On Neonc Technologies

A hedge fund recently bought a new stake in Neonc Technologies stock. Royal Bank of Canada purchased a new stake in shares of Neonc Technologies Holdings, Inc. (NASDAQ:NTHIFree Report) during the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 18,525 shares of the company’s stock, valued at approximately $247,000.

About Neonc Technologies

(Get Free Report)

Neonc Technologies Holdings, Inc develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. Its lead products in development include NEO100, which is in Phase 2a clinical trials for treating glioblastoma; and NEO212, a covalently conjugated molecule combining the chemotherapeutic drug temozolomide with perillyl alcohol that is completed preclinical testing.

Recommended Stories

Insider Buying and Selling by Quarter for Neonc Technologies (NASDAQ:NTHI)

Receive News & Ratings for Neonc Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neonc Technologies and related companies with MarketBeat.com's FREE daily email newsletter.